Inari Medical Inc. (NARI): Price and Financial Metrics
NARI Price/Volume Stats
| Current price | $37.93 | 52-week high | $71.85 |
| Prev. close | $38.59 | 52-week low | $36.73 |
| Day low | $36.73 | Volume | 1,139,200 |
| Day high | $38.71 | Avg. volume | 1,126,895 |
| 50-day MA | $46.69 | Dividend yield | N/A |
| 200-day MA | $57.57 | Market Cap | 2.20B |
NARI Stock Price Chart Interactive Chart >
Inari Medical Inc. (NARI) Company Bio
Inari Medical, Inc. operates as a medical device company. It develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Latest NARI News From Around the Web
Below are the latest news stories about INARI MEDICAL INC that investors may wish to consider to help them evaluate NARI as an investment opportunity.
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceIRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 9:45AM Pacific Time. A live audio webcast and replay of the presentation may be accessed for 30 days on the “Investor Relatio |
Reasons to Retain Inari Medical (NARI) in Your Portfolio NowInari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on the adoption of products is a concern. |
Why Is Steris (STE) Down 3.4% Since Last Earnings Report?Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Inari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue?Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Inari Medical's (NARI) PEERLESS II RCT to Boost Patient OutcomeInari Medical's (NARI) latest announcement of first patient enrollment in PEERLESS II RCT is likely to aid in changing guidelines in treating intermediate-risk PE patients globally. |
NARI Price Returns
| 1-mo | -14.42% |
| 3-mo | -32.58% |
| 6-mo | -31.96% |
| 1-year | -45.64% |
| 3-year | -65.02% |
| 5-year | N/A |
| YTD | -41.57% |
| 2023 | 2.14% |
| 2022 | -30.36% |
| 2021 | 4.56% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...